Aurinia Pharmaceuticals Inc

AUPHNASDAQ • USD
15.42 USD
↘ 0.31 (1.97%)🟢LIVE (AS OF 02:01 PM EST)
🟢Market: OPEN

Aurinia Pharmaceuticals Inc (AUPH) is currently trading at $15.42. The stock presents a mixed profile: our models indicate a Buy for underlying fundamentals, while technical indicators flash a Strong Sell. Notable factors include a robust Altman Z-Score, a strong Piotroski F-Score of 7/9, exceptional Return on Equity (47.8%) and a bullish Golden Cross on the moving averages. Valuation metrics place AUPH at a fair price relative to peers.

Technical & fundamental data as of Nov 13, 2026.

Open?$15.73
High?$16.15
Low?$15.29
Prev. Close?$15.73
Volume?403.2K
Avg. Volume?890.8K
VWAP?$15.53
Rel. Volume?0.45x
Bid / Ask
Bid?$15.43 × 100
Ask?$15.45 × 200
Spread?$0.02
Midpoint?$15.44
Valuation & Ratios
Market Cap?2.1B
Shares Out?134.0M
Float?107.3M
Float %?80.7%
P/E Ratio?6.71
P/B Ratio?3.21
EPS?$2.35
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
Employees
128
Market Cap
2.1B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2009-10-21
Address
#140, 14315 - 118 AVENUE
EDMONTON, A0 T5L 4S6
Phone: 250-744-2487
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
88
Z-Score?
100
Momentum?
73
Short Sent.?
61
Piotroski F-Score?7/9Strong
Altman Z-Score?8.27Safe
Confidence?71%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?6.65%Elevated
Short Interest?7.1M
Days to Cover?10.3
Free Float107.3M
Avg Daily Volume692.2K
Settlement Date2026-10-30
Financial Health
Current Ratio?6.12Strong
Quick Ratio?5.67Strong
Cash Ratio?0.48Low
Debt/Equity?0.08Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
72/100
P/E?
Peers
100
S&P
97
6.7CHEAP▾
P/B?
Peers
100
S&P
53
3.21FAIR▾
P/S?
Peers
100
S&P
19
6.55FAIR▾
P/FCF?
Peers
100
S&P
83
11.9CHEAP▾
EV/EBITDA?
Peers
100
S&P
61
13.1FAIR▾
EV/Sales?
Peers
100
S&P
23
6.58HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
91
47.8%STRONG▾
ROA?
Peers
50
S&P
97
38.1%STRONG▾
Cash Flow & Enterprise
FCF?$177.0M
Enterprise Value?$2.1B
Fundamentals ratios updated end of day